Effect of Zinc Supplementation on Red Blood Cell Osmotic Fragility in hemodialysis Patients

Authors

J Roozbeh 1, M Sharifian 2,*, M Karimi 3, AR Hamidian Jahromi 4, R Afshariani 5
1Associate Professor, Section of Nephrology, Department of Internal Medicine and Urology Nephrology Research Centre,
2Student of Medicine,
3Professor, Section of hematology, Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran,
4Registrar, Department of Transplant Surgery, Renal Transplant Unit, St Georges Hospital, London, United Kingdom,
5Pediatrician, Department of Public Health, School of Health and Nutrition, Shiraz University of Medical Sciences, Shiraz, Iran.
*Corresponding Author: Department of Internal Medicine ,Nemazee Hospital, Shiraz, Iran, [email protected]. Tel: +98-9177133608. Email: [email protected]

Shiraz E-Medical Journal:Vol. 10, issue 4; 186-9
Published online:Oct 01, 2009
Article type:Research Article
Received:Jun 24, 2009
Accepted:Aug 28, 2009
How to Cite:Roozbeh J, Sharifian M, Karimi M, Hamidian Jahromi A, Afshariani R. Effect of Zinc Supplementation on Red Blood Cell Osmotic Fragility in hemodialysis Patients. Shiraz E-Med J. 2009;10(4):. doi:

Abstract

Introduction:

Zinc deficiency may aggravate the effect of oxidative stress on RBC (Red Blood Cell) of chronic uremia. In this study, there is an attempt to show the relationship between the plasma zinc level and RBC osmotic fragility in hemodialysis patients.

Patients and Methods:

Thirty five patients with low level of serum zinc (serum zinc level<70) participated in the trial. RBC osmotic fragility, Hb (hemoglobin) and BUN (blood urea nitrogen) were checked. The patients received zinc supplement (zinc sulfate) (250 mg/day). Plasma level of zinc, Hb, BUN and osmotic fragility rechecked after 6 weeks.

Results:

The mean serum zinc concentration among the participants increased and it was statistically significant (p<0.05). Erythrocytes at day 0 (59+/_ 3.5) were significantly (P < 0.05) more fragile in hypotonie saline than those at day 43(38+/_ 2.9), (at NaCl 40%). No significant changes were noted in the level of Hb

Discussion:

In this trial, oral zinc supplementation caused a significant rises in the plasma zinc level after 6 weeks. Although Hb concentration was not changed during the trial the level of osmotic fragility in red cells reduced significantly.

KeywordsOsmotic

Full Text

Full text is available in PDF

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2010

Hematological parameters and osmotic fragility of red blood cells in experimentally induced hyperthyroidism in rats

Saleh Zahediasl,
Giti Habibi,
Asghar Ghasemi,
Shahrokh Pashaei Rad,
Nilufar Shiva

Zahediasl S, Habibi G, Ghasemi A, Pashaei Rad S, Shiva N. Hematological parameters and osmotic fragility of red blood cells in experimentally induced hyperthyroidism in rats. Int J Endocrinol Metab. 2010;8(2):. doi:

15
Sep
2024
The Role of Zinc Supplementation in Alleviating Inflammatory Biomarkers in Patients Undergoing Hemodialysis: A Randomized Placebo Controlled, Crossover Trial

The Role of Zinc Supplementation in Alleviating Inflammatory Biomarkers in Patients Undergoing Hemodialysis: A Randomized Placebo Controlled, Crossover Trial

Shayan Mastoor-Tehrani,
Fariba Samadian,
Hadi Esmaily,
Alireza Kargar,
Nasim Markazi,
Shideh Anvari
,et al.

Mastoor-Tehrani S, Samadian F, Esmaily H, Kargar A, Markazi N, et al. The Role of Zinc Supplementation in Alleviating Inflammatory Biomarkers in Patients Undergoing Hemodialysis: A Randomized Placebo Controlled, Crossover Trial. Iran J Pharm Res. 2024;23(1):e147887. doi: https://doi.org/10.5812/ijpr-147887

1
Apr
2018
The Role of Reticulocyte Hemoglobin Content in the Management of Iron Deficiency Anemia in Patients on Hemodialysis

The Role of Reticulocyte Hemoglobin Content in the Management of Iron Deficiency Anemia in Patients on Hemodialysis

Abdul Halim Abdul Gafor,
Ravih Subramaniam,
Firdaus Hadi,
Rizna Cader,
Kong Wei Yen,
Rozita Mohd
,et al.

Abdul Gafor AH, Subramaniam R, Hadi F, Cader R, Wei Yen K, et al. The Role of Reticulocyte Hemoglobin Content in the Management of Iron Deficiency Anemia in Patients on Hemodialysis. Nephro-Urol Mon. 2018;10(3):e65629. doi: https://doi.org/10.5812/numonthly.65629

26
Jun
2022
The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial

The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial

Seyede Fatemeh Ghasemian,
Shahla Ahmadi Halili,
Fatemeh Hayati,
Seyed Seifollah Beladi-Mousavi,
Shokouh Shayanpour,
Leila Sabetnia

Ghasemian SF, Ahmadi Halili S, Hayati F, Beladi-Mousavi SS, Shayanpour S, et al. The Effect of Vitamin D Deficiency Treatment on Hemoglobin Levels in Hemodialysis Patients: A Double-blind, Randomized Controlled Trial. Jundishapur J Chronic Dis Care. 2022;11(3):e119008. doi: https://doi.org/10.5812/jjcdc-119008

31
Jul
2007

Efficacy and Safety of Oral Versus Intravenous Vitamin C in Hemodialysis Patients with Functional Iron Deficiency

F Espahbodi,
Z Kashi,
S Ala,
N Hendoii

Espahbodi F, Kashi Z, Ala S, Hendoii N. Efficacy and Safety of Oral Versus Intravenous Vitamin C in Hemodialysis Patients with Functional Iron Deficiency. Int J Endocrinol Metab. 2007;5(3):. doi:

More by these authors

J RoozbehPubMedScholar
M SharifianPubMedScholar
AR Hamidian JahromiPubMedScholar
R AfsharianiPubMedScholar
Share
Cited by
Metrics